Drug development for neglected diseases: a deficient market and a public-health policy failure

This publication has 13 references indexed in Scilit:

• The AIDS Research Model
  Published by American Medical Association (AMA) ,2001
• Risks in new drug development: Approval success rates for investigational drugs
  Clinical Pharmacology & Therapeutics, 2001
• Drug Treatment of Tropical Parasitic Infections
  Drugs, 2000
• The New Drug Approvals of 1996, 1997, and 1998: Drug Development Trends in the User Fee Era
  Drug Information Journal, 2000
• Access to Essential Drugs in Poor CountriesA Lost Battle?
  JAMA, 1999
• Drug development output from 1975 to 1996: What proportion for tropical diseases?
  International Journal of Infectious Diseases, 1999
• Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D
  Drug Discovery Today, 1998
• Orphan Drug Development—International Program and Study Design Issues
  Drug Information Journal, 1998
• R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry
  International Journal of the Economics of Business, 1995
• Creating the Costliest Orphan:The Orphan Drug Act in the Development of Ceredase™
  International Journal of Technology Assessment in Health Care, 1992